Skip to content

News & Events

ORPHELIA at the 2018 ANR meeting in San Francisco

28 March 2018

Jeremy Bastid, Chief Development Officer of ORPHELIA Pharma, will attend the Advances in Neuroblastoma Research (ANR) 2018 conference, “Building Bridges for Neuroblastoma Research” in San Francisco, California from May 9-12, 2018.

Please meet us there (contact: